Evidence map›Paper›PMID 37507733›Full record

ArticleInternational journal for equity in health2023

Inequalities in the burden of non-communicable diseases across European countries: a systematic analysis of the Global Burden of Disease 2019 study.

Carlos Alexandre Soares Andrade, Nour Mahrouseh, Jonila Gabrani, Periklis Charalampous, Sarah Cuschieri, Diana Alecsandra Grad, Brigid Unim, Enkeleint A Mechili, José Chen-Xu, Brecht Devleesschauwer and 10 more

Open access · goldAbstract read
In one paragraph

Article in International journal for equity in health, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 35 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
35citing papers in PubMed, 2 pooled it
14.2field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

35 citing papers in PubMed, 2 syntheses or guidelines pooled it, 43 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Review
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Review
  16. Review
  17. Observational
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

20 authors at 17 institutions in 15 countries.

Carlos Alexandre Soares AndradeDepartment of Public Health and Epidemiology, Faculty of Medicine, University of Debrecen, 26 Kassai Street, 4028, Debrecen, Hungary.
Nour MahrousehDepartment of Public Health and Epidemiology, Faculty of Medicine, University of Debrecen, 26 Kassai Street, 4028, Debrecen, Hungary.
Jonila GabraniFaculty of Medicine, University of Basel, Basel, Switzerland.
Periklis CharalampousDepartment of Public Health, Erasmus MC University Medical Center, Rotterdam, The Netherlands.
Sarah CuschieriFaculty of Medicine and Surgery, University of Malta, Msida, Malta.
Diana Alecsandra GradDepartment of Public Health, Babes-Bolyai University, Cluj-Napoca-Napoca, Romania.
Brigid UnimDepartment of Cardiovascular, Endocrine-Metabolic Diseases and Aging, Istituto Superiore Di Sanità, Rome, Italy.
Enkeleint A MechiliDepartment of Healthcare, Faculty of Health, University of Vlora, Vlora, Albania.
José Chen-XuPublic Health Unit, Primary Healthcare Cluster Baixo Mondego, Coimbra, Portugal.
Brecht DevleesschauwerDepartment of Epidemiology and Public Health, Sciensano, Brussels, Belgium.
Gaetano IsolaDepartment of General Surgery and Surgical Medical Specialties, University of Catania, Catania, Italy.
Elena von der LippeDepartment of Epidemiology and Health Monitoring, Robert Koch Institute, Berlin, Germany.
Carl Michael BaravelliDepartment of Disease Burden, Norwegian Institute of Public Health, Bergen, Norway.
Florian FischerInstitute of Public Health, Charité - Universitätsmedizin Berlin, Berlin, Germany.
Nanna WeyeDepartment of Disease Burden, Norwegian Institute of Public Health, Bergen, Norway.
Mirza BalajDepartment of Sociology and Political Science, Centre for Global Health Inequalities Research (CHAIN), Norwegian University of Science and Technology (NTNU), Trondheim, Norway.
Romana HaneefDepartment of Non-Communicable Diseases and Injuries, Santé Publique France, Saint-Maurice, France.
Mary EconomouDepartment of Nursing, School of Health Sciences, Cyprus University of Technology, Limassol, Cyprus.
Juanita A HaagsmaDepartment of Public Health, Erasmus MC University Medical Center, Rotterdam, The Netherlands.
Orsolya VargaDepartment of Public Health and Epidemiology, Faculty of Medicine, University of Debrecen, 26 Kassai Street, 4028, Debrecen, Hungary. varga.orsolya@med.unideb.hu.
University of Debrecen · HUErasmus MC · NLAarhus University Hospital · DKBabeș-Bolyai University · ROCharité - Universitätsmedizin Berlin · DECyprus University of Technology · CYIstituto Superiore di Sanità · ITNorwegian Institute of Public Health · NONorwegian University of Science and Technology · NORobert Koch Institute · DESanté Publique France · FRSciensano (Belgium) · BEUniversidade Nova de Lisboa · PTUniversity of Basel · CHUniversity of Catania · ITUniversity of Crete · GRUniversity of Malta · MT

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundAlthough overall health status in the last decades improved, health inequalities due to non-communicable diseases (NCDs) persist between and within European countries. There is a lack of studies giving insights into health inequalities related to NCDs in the European Economic Area (EEA) countries. Therefore, the aim of the present study was to quantify health inequalities in age-standardized disability adjusted life years (DALY) rates for NCDs overall and 12 specific NCDs across 30 EEA countries between 1990 and 2019. Also, this study aimed to determine trends in health inequalities and to identify those NCDs where the inequalities were the highest.

methodsDALY rate ratios were calculated to determine and compare inequalities between the 30 EEA countries, by sex, and across time. Annual rate of change was used to determine the differences in DALY rate between 1990 and 2019 for males and females. The Gini Coefficient (GC) was used to measure the DALY rate inequalities across countries, and the Slope Index of Inequality (SII) to estimate the average absolute difference in DALY rate across countries.

resultsBetween 1990 and 2019, there was an overall declining trend in DALY rate, with larger declines among females compared to males. Among EEA countries, in 2019 the highest NCD DALY rate for both sexes were observed for Bulgaria. For the whole period, the highest DALY rate ratios were identified for digestive diseases, diabetes and kidney diseases, substance use disorders, cardiovascular diseases (CVD), and chronic respiratory diseases - representing the highest inequality between countries. In 2019, the highest DALY rate ratio was found between Bulgaria and Iceland for males. GC and SII indicated that the highest inequalities were due to CVD for most of the study period - however, overall levels of inequality were low.

conclusionsThe inequality in level 1 NCDs DALYs rate is relatively low among all the countries. CVDs, digestive diseases, diabetes and kidney diseases, substance use disorders, and chronic respiratory diseases are the NCDs that exhibit higher levels of inequality across countries in the EEA. This might be mitigated by applying tailored preventive measures and enabling healthcare access.

Indexed as

Cardiovascular DiseasesNoncommunicable DiseasesRespiratory Tract DiseasesFemaleGlobal Burden of DiseaseGlobal HealthHumansLife ExpectancyMaleQuality-Adjusted Life YearsDALY rateEuropean Economic AreaEuropean UnionGlobal Burden of DiseaseHealth inequalityNon-communicable diseases

Identifiers

PMID37507733
PMCPMC10375608
OpenAlexW4385345389

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.